The abstract is read at the publisher; the summary is JClub's.
Higher measured lipoprotein(a) levels are associated with incident venous thromboembolism in this cohort study, quantifying risk across participants.
- Why it matters: Venous thromboembolism risk prediction needs clearer biomarkers, and lipoprotein(a) has been proposed as a potential contributor.
- What they did: In a cohort design, investigators measured lipoprotein(a) levels and tracked participants for incident venous thromboembolism.
- The result: The study links lipoprotein(a) level to future venous thromboembolism occurrence, supporting its consideration for risk assessment in similar cohorts.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.